Fortress Biotech Inc <FBIO.OQ> expected to post a loss of 49 cents a share - Earnings Preview

• Fortress Biotech Inc FBIO.OQ FBIO.O is expected to show a fall in quarterly revenue when it reports results on August 11 (estimated) for the period ending March 31 2025

• The Bay Harbor Islands Florida-based company is expected to report a 10.8% decrease in revenue to $11.621 million from $13.03 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Fortress Biotech Inc is for a loss of 49 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Fortress Biotech Inc is $16.00​, above​ its last closing price of $1.78. ​​​

This summary was machine generated May 16 at 20:54 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)